Superseded · version 1: Retatrutide^↗

Related names recorded in this version: LY3437943^↗

A multi-receptor metabolic candidate with active ClinicalTrials.gov records.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists an Eli Lilly study as active, not recruiting, with a registry update posted July 20, 2026.^↗

Organizations named in cited records:

Trial records: NCT06297603